Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$361,800.00
Apr 1, 2012
The gene regulatory network underpinning IL17-mediated innate immunity in the gut.
$361,539.00
Apr 1, 2012
Polymer-based Gene Delivery for Rheumatoid Arthritis
$748,120.00
Apr 1, 2012
Acute lung injury: from cellular mechanisms to molecular therapies
$135,000.00
Apr 1, 2012
Early life gene-environment interactions and hypothalamic-pituitary-adrenal (HPA) axis function
$137,483.00
Apr 1, 2012
Validating a new cognitive-behavioural therapy for compulsive checking in OCD
$763,865.00
Apr 1, 2012
Roles of human RNA polymerase II CTD-interacting proteins in the regulation of gene expression
$291,680.00
Apr 1, 2012
Ultrasound-targeted gene delivery to enhance cell engraftment in the aged heart after ischemic injury
$558,000.00
Apr 1, 2012
Toward a rational and novel therapy for clostridium difficile infection
$557,347.00
Apr 1, 2012
Pathogenesis of fetal and neonatal alloimmune thrombocytopenia and mechanisms of IVIG and anti-FcRn therapies
$135,000.00
Apr 1, 2012
Chemical biology approaches to understanding glycosylation mediated gene silencing